MSH6 and colorectal carcinoma: The aim of this study was to investigate the contribution of mutations in MSH6 in 97 CRC patients belonging to 74 Lynch families, already negative for germline mutations in MLH1 and MSH2. We report several molecular variants in our Lynch patients, of which nine are novel variants.